The FDA has received more than 400 reports of possible problems in patients taking Heparin made by several manufacturers, but the agency says that 215 allergic reactions, including four deaths, were linked to the Baxter product.
Problems found at Heparin factory
Baxter International recalled the drug and stopped making it earlier in February.
